Losartan Potassium Tablet, Film Coated
Product Images NDC 68071-4471

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68071-4471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4471 3

This is a description of pharmaceutical product called Losartan Potassium 50mg manufactured by NuCare Pharmaceuticals, Inc. The product comes in the form of 30 tablets in a bottle with lot number 000000. The NDC numbers are 68071-4471-3 and 31722-701-30, and the expiration date is 00-00. It is the prescription medicine and only used as directed by a physician. The product contains some specific ingredients which can be found in the manufacturer's label. It has a warning message that it should be kept out of reach of children and be stored at a controlled temperature of 68-77°F.*

FDA Label Image

Losartanaddress1 (Losartanaddress1)

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

The given text seems to be a statistical analysis result of a study. The study examines the adjusted risk reduction percentage, which amounts to 26% with a p-value of 0.001. The rest of the text seems to be a graphical representation, as it shows months on the X-axis and the percentage of patients with either fatal or non-fatal stroke on the Y-axis. Hence, it is likely a part of a graph or chart accompanying the study.*

FDA Label Image

Losartanfigure3 (Losartanfigure3)

FDA Label Image

Losartanfigure4 (Losartanfigure4)

The text is a table representation showing the percentage of patents with events and risk reduction in a particular time period of months. The specific details of the events and risk reduction are not available.*

FDA Label Image

Losartanstructure (Losartanstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.